Market research
BDA.AU Bod Australia Limited
AU AUD Consumer Defensive
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 29M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.12
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- ISIN
- AU0000181331
- Market cap
- 29M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.12
About
About Bod Australia Limited
Bod Australia Limited operates as a cannabidiol and medical cannabis healthcare company in Australia, the United Kingdom, the European Union, and the United States. The company operates through three segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, and OTC Herbals. It engages in the development and manufacture of cannabidiol and hemp products for consumers; and development, manufacture, and distribution of therapeutics medicinal cannabis products for medical markets. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long-term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.
Research context
Bod Australia Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the BDA.AU discussion.
5 years, 6 months ago
Bod Australia Limited is currently in a long term downtrend where the price is trading 31.0% below its 200 day moving average.
From a valuation standpoint, the stock is 1.6% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 6.9.
Bod Australia Limited's total revenue rose by 58.9% to $3M since the same quarter in the previous year.
Its net income has increased by 8.4% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 82.7% to $-2M since the same quarter in the previous year.
Based on the above factors, Bod Australia Limited gets an overall score of 2/5.